FDA approves GlucoGorx Glucose Monitoring Test Kit from Innovus Pharmaceuticals, Inc.

Innovus Pharmaceuticals, Inc. an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men�s and women's health and respiratory diseases, announced that the FDA has cleared the Company�s GlucoGorx Glucose Monitoring Test Kit that includes a glucose meter, test strips and lancet device (�GlucoGorx� Kit�) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc.

Innovus Pharma will offer the GlucoGorx� Kit, which will provide highly sensitive glucose level testing results within 4 seconds, to its customers who buy its GlucoGorx clinical glucose supplement. Innovus Pharma is expected to launch its GlucoGorx Kit and GlucoGorx in the second half of 2018. With an FDA-cleared glucometer and test strips, Innovus Pharma is now eligible to enter reimbursement and government supply programs, expanding the addressable market significantly for this product. To date, the Company has received notification that the GlucoGorx� Kit is eligible for Medicare Part B reimbursement for its customers.